Glenn D. Hanson
Papers
1
Total Citations
32
H-Index
1
About
Glenn D. Hanson is a distinguished analytical chemist whose work has significantly advanced the field of bioanalytical mass spectrometry, particularly in the quantification of pharmaceutical compounds in biological matrices. His research focuses on developing robust, sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for the simultaneous determination of opioids and their metabolites in human plasma, a critical area for therapeutic drug monitoring and forensic toxicology. Hanson’s most-cited paper, a 2002 study on the simultaneous determination of hydrocodone and hydromorphone, has garnered 32 citations and stands as a foundational contribution to opioid analysis. This work exemplifies his ability to create precise, high-throughput assays that enable accurate pharmacokinetic profiling and clinical research. By refining sample preparation and chromatographic separation techniques, Hanson has helped improve the reliability of drug quantification in complex biological samples, directly supporting studies on pain management, addiction treatment, and drug safety. His methodical approach and attention to analytical validation have made his protocols a benchmark for subsequent researchers in pharmaceutical analysis. Hanson’s contributions, though focused, have had a lasting impact on the rigorous application of mass spectrometry in clinical and forensic settings.
Research Focus
Key Achievements
Top Papers
- 1